• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

潜在抗白内障药物在预防蛋白质糖基化方面的有效性。

The effectiveness of putative anti-cataract agents in the prevention of protein glycation.

作者信息

Stevens A

机构信息

National Vision Research Institute of Australia, Carlton, Australia.

出版信息

J Am Optom Assoc. 1995 Dec;66(12):744-9.

PMID:8557952
Abstract

BACKGROUND

Recent data have favored non-enzymatic glycation as a likely mechanism in diabetic cataract formation. The advanced glycation end products (AGEs) that are formed lead to opacification of the lens by disrupting the short-range order between the proteins. Attempts to decrease AGE formation has led to the use of various anti-glycating agents. Their efficacy, however, has been questionable.

METHODS

The extent of AGE formation was monitored in fetal bovine eyes using non-tryptophan fluorescence. The amount of carbohydrate bound to the proteins was measured after reduction with radio-labelled sodium borohydride.

RESULTS

While the addition of glucose, glucose-6-phosphate or fructose increased the levels of glycation by only 25 percent and the levels of AGEs by 40 percent, glyceraldehyde resulted in a 70 percent increase in glycation and showed extensive AGE formation (an increase of over 6600 percent when compared to the unglycated protein). The anti-glycating agents aspirin and ibuprofen were unable to significantly decrease the extent of bound metabolite or reduce the amount of AGE formed. In contrast, penicillamine and aminoguanidine were more effective in reducing the levels of AGEs, even though the levels of bound metabolite appeared unchanged.

CONCLUSIONS

Triose phosphates are likely to be the major metabolic intermediates that result in AGE formation. The anti-glycating agents, whereas penicillamine and aminoguanidine-which react with the Amadori-derived fragmentation products-significantly decreased levels of AGEs.

摘要

背景

近期数据表明,非酶糖基化可能是糖尿病性白内障形成的机制。所形成的晚期糖基化终产物(AGEs)通过破坏蛋白质间的短程有序结构导致晶状体混浊。降低AGE形成的尝试促使人们使用各种抗糖基化剂。然而,它们的疗效一直存在疑问。

方法

使用非色氨酸荧光监测胎牛眼内AGE的形成程度。用放射性标记的硼氢化钠还原后,测量与蛋白质结合的碳水化合物量。

结果

虽然添加葡萄糖、6-磷酸葡萄糖或果糖仅使糖基化水平增加25%,AGE水平增加40%,但甘油醛使糖基化水平增加70%,并显示出大量AGE形成(与未糖基化蛋白质相比增加超过6600%)。抗糖基化剂阿司匹林和布洛芬不能显著降低结合代谢物的程度或减少AGE的形成量。相比之下,青霉胺和氨基胍在降低AGE水平方面更有效,尽管结合代谢物的水平似乎没有变化。

结论

磷酸丙糖可能是导致AGE形成的主要代谢中间体。抗糖基化剂中,与阿马多利衍生的裂解产物反应的青霉胺和氨基胍显著降低了AGE水平。

相似文献

1
The effectiveness of putative anti-cataract agents in the prevention of protein glycation.潜在抗白内障药物在预防蛋白质糖基化方面的有效性。
J Am Optom Assoc. 1995 Dec;66(12):744-9.
2
The contribution of glycation to cataract formation in diabetes.糖基化对糖尿病性白内障形成的作用。
J Am Optom Assoc. 1998 Aug;69(8):519-30.
3
Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats.原儿茶醛对糖尿病条件下培养的人晶状体上皮细胞中晚期糖基化终产物受体及转化生长因子-β1表达的影响以及对链脲佐菌素诱导的糖尿病大鼠晶状体混浊的影响。
Eur J Pharmacol. 2007 Aug 27;569(3):171-9. doi: 10.1016/j.ejphar.2007.05.054. Epub 2007 Jun 9.
4
Immunochemical evidence for increased formation of advanced glycation end products and inhibition by aminoguanidine in diabetic rat lenses.糖尿病大鼠晶状体中晚期糖基化终产物生成增加及氨基胍抑制作用的免疫化学证据。
Biochem Biophys Res Commun. 1997 Dec 18;241(2):352-4. doi: 10.1006/bbrc.1997.7744.
5
Fluorescence and immunochemical studies of advanced glycation-related lens pigments.晚期糖基化相关晶状体色素的荧光和免疫化学研究。
Invest Ophthalmol Vis Sci. 1998 Oct;39(11):2058-66.
6
Inhibition of cataracts in moderately diabetic rats by aminoguanidine.氨基胍对中度糖尿病大鼠白内障的抑制作用。
Exp Eye Res. 1996 May;62(5):505-10. doi: 10.1006/exer.1996.0061.
7
Immunochemical detection of glycated beta- and gamma-crystallins in lens and their circulating autoantibodies (IgG) in streptozocin induced diabetic rat.链脲佐菌素诱导的糖尿病大鼠晶状体中糖化β-和γ-晶状体蛋白及其循环自身抗体(IgG)的免疫化学检测
Mol Vis. 2006 Sep 13;12:1077-85.
8
Advanced glycation end products in vitreous: Structural and functional implications for diabetic vitreopathy.玻璃体中的晚期糖基化终产物:对糖尿病性玻璃体病变的结构和功能影响
Invest Ophthalmol Vis Sci. 1998 Dec;39(13):2517-23.
9
Transition metal-catalyzed oxidation of ascorbate in human cataract extracts: possible role of advanced glycation end products.过渡金属催化人白内障提取物中抗坏血酸的氧化:晚期糖基化终产物的可能作用。
Invest Ophthalmol Vis Sci. 2000 May;41(6):1473-81.
10
Ilex paraguariensis extracts inhibit AGE formation more efficiently than green tea.巴拉圭冬青提取物比绿茶更有效地抑制晚期糖基化终末产物的形成。
Fitoterapia. 2005 Jul;76(5):419-27. doi: 10.1016/j.fitote.2005.03.021.

引用本文的文献

1
Prevention of non-enzymatic glycosylation (glycation): Implication in the treatment of diabetic complication.非酶糖基化(糖基化)的预防:对糖尿病并发症治疗的意义。
Int J Health Sci (Qassim). 2016 Apr;10(2):261-77.
2
The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach.晚期糖基化终产物在各类神经退行性疾病中的作用:一种治疗方法。
Cell Mol Biol Lett. 2014 Sep;19(3):407-37. doi: 10.2478/s11658-014-0205-5. Epub 2014 Aug 20.
3
The combined effect of acetylation and glycation on the chaperone and anti-apoptotic functions of human α-crystallin.
乙酰化和糖基化对人α-晶体蛋白伴侣功能和抗凋亡功能的联合作用。
Biochim Biophys Acta. 2013 Jan;1832(1):195-203. doi: 10.1016/j.bbadis.2012.08.015. Epub 2012 Sep 8.
4
Vitamin C-mediated Maillard reaction in the lens probed in a transgenic-mouse model.在转基因小鼠模型中探究晶状体中维生素C介导的美拉德反应。
Ann N Y Acad Sci. 2008 Apr;1126:194-200. doi: 10.1196/annals.1433.064.
5
Inhibition of crystallin ascorbylation by nucleophilic compounds in the hSVCT2 mouse model of lenticular aging.在晶状体老化的hSVCT2小鼠模型中亲核化合物对晶状体蛋白抗坏血酸化的抑制作用
Invest Ophthalmol Vis Sci. 2008 Nov;49(11):4945-52. doi: 10.1167/iovs.08-1813. Epub 2008 Apr 17.
6
Triosidines: novel Maillard reaction products and cross-links from the reaction of triose sugars with lysine and arginine residues.三糖胺:来自三碳糖与赖氨酸和精氨酸残基反应的新型美拉德反应产物及交联物。
Biochem J. 2003 Feb 1;369(Pt 3):705-19. doi: 10.1042/BJ20020668.